EUVIMEDEUVIMED entdecken
Crossref

Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous Leukemia

Ning Li, Yunyu Feng, Nan Wang, Wei He, Hongjian Li, Xue Cui, Bochuan Wang, Runkuan Qin, Huandi Qiu, Qiang Qiu, Li Zheng, Yuanyuan Sun und 5 weitere

The American Journal of Pathology · 2026

DOI: 10.1016/j.ajpath.2025.12.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2026. Verfasst von Ning Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Nuclear Receptor Subfamily 1, Group F, Member 1. Die Arbeit nennt 65 Literaturangaben. Gefördert von: Key Research and Development Program of Sichuan Province, National Natural Science Foundation of China, Science and Technology Program of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNuclear Receptor Subfamily 1, Group F, Member 1AnimalsPhenotypeMiceDisease ProgressionCell ProliferationHumansCellular Senescence

Substanzen

Nuclear Receptor Subfamily 1, Group F, Member 1

Autor:innen und Institutionen

  • State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China; Department of Clinical Translational Innovation Center and Molecular Medicine Research Center, State Key Laboratory of Biother…
  • Institute for Immunology and School of Medicine, Tsinghua University, Beijing, China.
  • Department of Hematology and Research Laboratory of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China; Institute of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China; Department of Thyroid Surgery, West China Hospital,…

Förderung

  • Key Research and Development Program of Sichuan Province
  • National Natural Science Foundation of China
  • Science and Technology Program of Guizhou Province

Zitieren

APA

Li, N., Feng, Y., Wang, N., He, W., Li, H., Cui, X., Wang, B., Qin, R., Qiu, H., Qiu, Q., Zheng, L., Sun, Y., He, L., Pan, C., Su, A., Li, Z., & Hu, Y. (2026). Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous Leukemia. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2025.12.010

Vancouver

Li N, Feng Y, Wang N, He W, Li H, Cui X, et al. Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous Leukemia. The American Journal of Pathology. 2026. doi:10.1016/j.ajpath.2025.12.010

BibTeX
@article{Li2026,
  author = {Li, Ning and Feng, Yunyu and Wang, Nan and He, Wei and Li, Hongjian and Cui, Xue and Wang, Bochuan and Qin, Runkuan and Qiu, Huandi and Qiu, Qiang and Zheng, Li and Sun, Yuanyuan and He, Linye and Pan, Cong and Su, Anping and Li, Zhihui and Hu, Yiguo},
  title = {Rora Regulates Hematopoietic Stem Cell Phenotypes and Progression of Chronic Myelogenous Leukemia},
  journal = {The American Journal of Pathology},
  year = {2026},
  doi = {10.1016/j.ajpath.2025.12.010}
}
Kostenlos starten →